MSK
Search
- Page Path
- HOME > Search
Review
- Coronavirus enzyme inhibitors-experimentally proven natural compounds from plants
- Junsoo Park , Rackhyun Park , Minsu Jang , Yea-In Park , Yeonjeong Park
- J. Microbiol. 2022;60(3):347-354. Published online January 28, 2022
- DOI: https://doi.org/10.1007/s12275-022-1499-z
- 56 View
- 0 Download
- 7 Web of Science
- 7 Crossref
-
Abstract
- Coronavirus disease (COVID-19) can cause critical conditions that require efficient therapeutics. Several medicines are derived from plants, and researchers are seeking natural compounds to ameliorate the symptoms of COVID-19. Viral enzymes are popular targets of antiviral medicines; the genome of coronaviruses encodes several enzymes, including RNAdependent RNA polymerase and viral proteases. Various screening systems have been developed to identify potential inhibitors. In this review, we describe the natural compounds that have been shown to exert inhibitory effects on coronavirus enzymes. Although computer-aided molecular structural studies have predicted several antiviral compound candidates, the current review focuses on experimentally proven natural compounds.
-
Citations
Citations to this article as recorded by
- Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
Yea-In Park, Jang Hoon Kim, Siyun Lee, Ik Soo Lee, Junsoo Park
International Journal of Molecular Sciences.2023; 24(11): 9211. CrossRef - Structural Insights into Plasticity and Discovery of Flavonoid Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease
Marielena Vogel Saivish, Gabriela de Lima Menezes, Vivaldo Gomes da Costa, Liliane Nebo, Gislaine Celestino Dutra da Silva, Carolina Colombelli Pacca, Rafael Elias Marques, Maurício Lacerda Nogueira, Roosevelt Alves Da Silva
Biophysica.2023; 3(1): 71. CrossRef - Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, Uddhab Karki, Jianfeng Xu
Life.2023; 13(3): 617. CrossRef - Computational investigation of natural compounds as potential main protease (Mpro) inhibitors for SARS-CoV-2 virus
Chirag N. Patel, Siddhi P. Jani, Sivakumar Prasanth Kumar, Krunal M. Modi, Yogesh Kumar
Computers in Biology and Medicine.2022; 151: 106318. CrossRef - Two years of COVID-19 pandemic: where are we now?
Jinjong Myoung
Journal of Microbiology.2022; 60(3): 235. CrossRef - Identification of SARS-CoV-2 Main Protease Inhibitors from a Library of Minor Cannabinoids by Biochemical Inhibition Assay and Surface Plasmon Resonance Characterized Binding Affinity
Chang Liu, Tess Puopolo, Huifang Li, Ang Cai, Navindra P. Seeram, Hang Ma
Molecules.2022; 27(18): 6127. CrossRef - Computational Approaches in the Discovery and Development of Therapeutic
and Prophylactic Agents for Viral Diseases
Anand Gaurav, Neetu Agrawal, Mayasah Al-Nema, Vertika Gautam
Current Topics in Medicinal Chemistry.2022; 22(26): 2190. CrossRef
- Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
First
Prev
TOP
